Background
Introduction of autism spectrum disorder
The risk of the rs3747333 and rs3747334 in the autism spectrum disorder
Objective
Materials and methods
Literature search and selection strategy
Inclusion criteria
Data extraction
Statistical analysis
Results
Meta-analyses of the rs3747333, rs3747334 in NLGN4X and ASD
Author, year | Ethnicity | Study design | Presence in patients/sex ratio | Presence in controls/sex ratio | Genotyping type | Diagnostic criteria | Nucleotide change | ||
---|---|---|---|---|---|---|---|---|---|
Mikhailov (2014) | Thai | Screening | 9/143 | 5.8 M:1F | vs.dpSNP | Unknown | DHPLCa | DSM-IVd | c.1777 C>T c.17779C>G |
Volaki (2013) | Greek | Screening | 11/40 | 9 M:1F | vs.dpSNP | Unknown | PCR-DSb | DSM-IV | c.1777 C>T c.17779C>G |
Wermter (2008) | German | Screening | 7/107 | 20.4 M:1F | vs.dpSNP | Unknown | PCR–RFLPc | ICD-10e | c.1777 C>T c.17779C>G |
Blasi (2006) | Italy | Screening | 4/31 | 3.5 M:1F | vs.dpSNP | Unknown | PCR-RFLPc | DSM-IV | c.1777 C>T c.17779C>G |
Gauthier (2005) | Quebec | Case–control | 61/96 | 6.4 M:1F | 56/96 | 8.6 M:1F | NA | DSM-IV, ADI-Rf and ADOS-Gg | c.1777 C>T c.17779C>G |
Xiaojuan (2014) | Chinese | Case–control | 21/318 | 5.6 M:1F | 4/453 | 3.0 M:1F | PCR-DS | DSM-IV and CARSh | c.1777 C>T c.17779C>G |